Jaguar Animal Health (JAGX) Competitors

$3.70 -0.22 (-5.61%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$3.76 +0.06 (+1.62%)

As of 06:11 AM Eastern

JAGX vs. SNYR, GELS, PULM, QUCY, and SXTP

Should you buy Jaguar Animal Health stock or one of its competitors? MarketBeat compares Jaguar Animal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Jaguar Animal Health include Synergy CHC (SNYR), Gelteq (GELS), Pulmatrix (PULM), Mainz Biomed (QUCY), and 60 Degrees Pharmaceuticals (SXTP). These companies are all part of the "pharmaceutical products" industry.

How does Jaguar Animal Health compare to Synergy CHC?

Synergy CHC (NASDAQ:SNYR) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap pharmaceutical products companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Synergy CHC has a net margin of -60.02% compared to Jaguar Animal Health's net margin of -464.20%. Synergy CHC's return on equity of -19.51% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	-19.51%	-30.30%
Jaguar Animal Health	-464.20%	-1,194.94%	-114.26%

12.0% of Jaguar Animal Health shares are owned by institutional investors. 56.6% of Synergy CHC shares are owned by company insiders. Comparatively, 2.1% of Jaguar Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Synergy CHC has a beta of -0.26, indicating that its stock price is 126% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the broader market.

Synergy CHC has higher revenue and earnings than Jaguar Animal Health. Synergy CHC is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$30.38M	0.14	-$12.34M	-$1.40	N/A
Jaguar Animal Health	$11.51M	0.12	-$53.43M	-$1.16 thousand	N/A

In the previous week, Synergy CHC had 3 more articles in the media than Jaguar Animal Health. MarketBeat recorded 4 mentions for Synergy CHC and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.50 beat Synergy CHC's score of -0.11 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Synergy CHC	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Synergy CHC presently has a consensus target price of $6.25, suggesting a potential upside of 2,164.49%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synergy CHC is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Synergy CHC beats Jaguar Animal Health on 12 of the 16 factors compared between the two stocks.

How does Jaguar Animal Health compare to Gelteq?

Gelteq (NASDAQ:GELS) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, institutional ownership, earnings, media sentiment, valuation, risk and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Gelteq	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Gelteq and Gelteq both had 1 articles in the media. Gelteq's average media sentiment score of 0.72 beat Jaguar Animal Health's score of 0.50 indicating that Gelteq is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Gelteq	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

12.0% of Jaguar Animal Health shares are held by institutional investors. 2.1% of Jaguar Animal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Gelteq has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of 0.01, indicating that its share price is 99% less volatile than the broader market.

Gelteq has higher earnings, but lower revenue than Jaguar Animal Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Gelteq	$110K	39.43	-$4.30M	N/A	N/A
Jaguar Animal Health	$11.51M	0.12	-$53.43M	-$1.16 thousand	N/A

Gelteq has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -464.20%. Gelteq's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Gelteq	N/A	N/A	N/A
Jaguar Animal Health	-464.20%	-1,194.94%	-114.26%

Summary

Gelteq beats Jaguar Animal Health on 7 of the 10 factors compared between the two stocks.

How does Jaguar Animal Health compare to Pulmatrix?

Pulmatrix (NASDAQ:PULM) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Pulmatrix has a beta of 1.94, meaning that its stock price is 94% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of 0.01, meaning that its stock price is 99% less volatile than the broader market.

Pulmatrix has higher earnings, but lower revenue than Jaguar Animal Health. Pulmatrix is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulmatrix	$7.81M	0.59	-$5.16M	-$1.23	N/A
Jaguar Animal Health	$11.51M	0.12	-$53.43M	-$1.16 thousand	N/A

Pulmatrix has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -464.20%. Pulmatrix's return on equity of -95.98% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulmatrix	N/A	-95.98%	-88.90%
Jaguar Animal Health	-464.20%	-1,194.94%	-114.26%

11.8% of Pulmatrix shares are owned by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are owned by institutional investors. 0.6% of Pulmatrix shares are owned by insiders. Comparatively, 2.1% of Jaguar Animal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulmatrix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Pulmatrix had 3 more articles in the media than Jaguar Animal Health. MarketBeat recorded 4 mentions for Pulmatrix and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.50 beat Pulmatrix's score of 0.34 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulmatrix	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pulmatrix beats Jaguar Animal Health on 8 of the 13 factors compared between the two stocks.

How does Jaguar Animal Health compare to Mainz Biomed?

Jaguar Animal Health (NASDAQ:JAGX) and Mainz Biomed (NASDAQ:QUCY) are both small-cap pharmaceutical products companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

12.0% of Jaguar Animal Health shares are held by institutional investors. 2.1% of Jaguar Animal Health shares are held by insiders. Comparatively, 9.8% of Mainz Biomed shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Mainz Biomed has a net margin of 0.00% compared to Jaguar Animal Health's net margin of -464.20%. Mainz Biomed's return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jaguar Animal Health	-464.20%	-1,194.94%	-114.26%
Mainz Biomed	N/A	N/A	N/A

Mainz Biomed has lower revenue, but higher earnings than Jaguar Animal Health. Mainz Biomed is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jaguar Animal Health	$11.51M	0.12	-$53.43M	-$1.16 thousand	N/A
Mainz Biomed	$537.08K	76.90	-$16.21M	-$65.60	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Mainz Biomed	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Jaguar Animal Health has a beta of 0.01, suggesting that its share price is 99% less volatile than the broader market. Comparatively, Mainz Biomed has a beta of 0.42, suggesting that its share price is 58% less volatile than the broader market.

In the previous week, Mainz Biomed had 17 more articles in the media than Jaguar Animal Health. MarketBeat recorded 18 mentions for Mainz Biomed and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.50 beat Mainz Biomed's score of 0.19 indicating that Jaguar Animal Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Mainz Biomed	0 Very Positive mention(s)	1 Positive mention(s)	16 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Mainz Biomed beats Jaguar Animal Health on 10 of the 14 factors compared between the two stocks.

How does Jaguar Animal Health compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTP) and Jaguar Animal Health (NASDAQ:JAGX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, media sentiment, earnings, analyst recommendations and dividends.

8.0% of 60 Degrees Pharmaceuticals shares are held by institutional investors. Comparatively, 12.0% of Jaguar Animal Health shares are held by institutional investors. 1.7% of 60 Degrees Pharmaceuticals shares are held by company insiders. Comparatively, 2.1% of Jaguar Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

60 Degrees Pharmaceuticals presently has a consensus target price of $14.10, suggesting a potential upside of 879.17%. Given 60 Degrees Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe 60 Degrees Pharmaceuticals is more favorable than Jaguar Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
60 Degrees Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Jaguar Animal Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Jaguar Animal Health has a net margin of -464.20% compared to 60 Degrees Pharmaceuticals' net margin of -574.83%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Jaguar Animal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	-574.83%	N/A	-139.68%
Jaguar Animal Health	-464.20%	-1,194.94%	-114.26%

60 Degrees Pharmaceuticals has a beta of 2.69, suggesting that its stock price is 169% more volatile than the broader market. Comparatively, Jaguar Animal Health has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Jaguar Animal Health. MarketBeat recorded 3 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Jaguar Animal Health. Jaguar Animal Health's average media sentiment score of 0.50 beat 60 Degrees Pharmaceuticals' score of -0.28 indicating that Jaguar Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
60 Degrees Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Jaguar Animal Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Jaguar Animal Health. 60 Degrees Pharmaceuticals is trading at a lower price-to-earnings ratio than Jaguar Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.01M	3.78	-$7.36M	-$13.88	N/A
Jaguar Animal Health	$11.51M	0.12	-$53.43M	-$1.16 thousand	N/A

Summary

60 Degrees Pharmaceuticals beats Jaguar Animal Health on 9 of the 16 factors compared between the two stocks.

Get Jaguar Animal Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAGX vs. The Competition

Export

Metric	Jaguar Animal Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.46M	$3.00B	$6.25B	$12.29B
Dividend Yield	N/A	1.98%	2.80%	5.32%
P/E Ratio	0.00	17.22	20.64	25.23
Price / Sales	0.12	286.32	554.85	79.36
Price / Cash	N/A	56.35	27.48	37.30
Price / Book	-0.03	3.93	9.66	6.63
Net Income	-$53.43M	$74.99M	$3.56B	$335.59M
7 Day Performance	13.85%	-4.47%	-1.65%	-1.20%
1 Month Performance	-73.30%	-7.93%	-2.60%	-1.16%
1 Year Performance	-98.16%	29.34%	30.07%	28.10%

Jaguar Animal Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAGX Jaguar Animal Health	0.4429 of 5 stars	$3.70 -5.6%	N/A	-98.2%	$1.46M	$11.51M	N/A	50
SNYR Synergy CHC	3.7243 of 5 stars	$0.31 -5.9%	$6.25 +1,922.0%	-88.4%	$4.61M	$30.38M	N/A	40	News Coverage Positive News Earnings Report Gap Down
GELS Gelteq	1.3326 of 5 stars	$0.43 -4.5%	N/A	-78.8%	$4.60M	$110K	N/A	N/A	Short Interest Decrease High Trading Volume
PULM Pulmatrix	0.7146 of 5 stars	$1.25 flat	N/A	-80.6%	$4.56M	$7.81M	N/A	20	Earnings Report Short Interest Increase
QUCY Mainz Biomed	0.5381 of 5 stars	$0.32 -5.6%	N/A	N/A	$4.04M	$540K	N/A	30	News Coverage Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:JAGX) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Jaguar Animal Health (JAGX) Competitors

JAGX vs. SNYR, GELS, PULM, QUCY, and SXTP

How does Jaguar Animal Health compare to Synergy CHC?

Summary

How does Jaguar Animal Health compare to Gelteq?

Summary

How does Jaguar Animal Health compare to Pulmatrix?

Summary

How does Jaguar Animal Health compare to Mainz Biomed?

Summary

How does Jaguar Animal Health compare to 60 Degrees Pharmaceuticals?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Jaguar Animal Health (JAGX) Competitors

JAGX vs. SNYR, GELS, PULM, QUCY, and SXTP

How does Jaguar Animal Health compare to Synergy CHC?

Is SNYR or JAGX more profitable?

Do insiders and institutionals have more ownership in SNYR or JAGX?

Which has more volatility & risk, SNYR or JAGX?

Which has better valuation and earnings, SNYR or JAGX?

Does the media prefer SNYR or JAGX?

Do analysts prefer SNYR or JAGX?

Summary

How does Jaguar Animal Health compare to Gelteq?

Do analysts prefer GELS or JAGX?

Does the media prefer GELS or JAGX?

Do institutionals & insiders have more ownership in GELS or JAGX?

Which has more risk and volatility, GELS or JAGX?

Which has higher earnings & valuation, GELS or JAGX?

Is GELS or JAGX more profitable?

Summary

How does Jaguar Animal Health compare to Pulmatrix?

Which has more volatility and risk, PULM or JAGX?

Which has better earnings and valuation, PULM or JAGX?

Is PULM or JAGX more profitable?

Do institutionals and insiders hold more shares of PULM or JAGX?

Do analysts prefer PULM or JAGX?

Does the media refer more to PULM or JAGX?

Summary

How does Jaguar Animal Health compare to Mainz Biomed?

Do institutionals & insiders have more ownership in JAGX or QUCY?

Is JAGX or QUCY more profitable?

Which has stronger earnings and valuation, JAGX or QUCY?

Do analysts rate JAGX or QUCY?

Which has more volatility & risk, JAGX or QUCY?

Does the media favor JAGX or QUCY?

Summary

How does Jaguar Animal Health compare to 60 Degrees Pharmaceuticals?

Do institutionals and insiders have more ownership in SXTP or JAGX?

Do analysts rate SXTP or JAGX?

Is SXTP or JAGX more profitable?

Which has more risk and volatility, SXTP or JAGX?

Does the media refer more to SXTP or JAGX?

Which has better valuation and earnings, SXTP or JAGX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAGX vs. The Competition

Jaguar Animal Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools